Point72 Asia (Singapore)’s AstraZeneca AZN Stock Holding History

Point72 Asia (Singapore)’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$202K	Buy	+1,318	New	+$199K	0.03%	300
2025 Q2	–	Sell	-321	Closed	-$47.2K	–	890
2025 Q1	$47.2K	Buy	+321	New	+$46.4K	0.01%	582
2024 Q3	–	Sell	-864	Closed	-$135K	–	972
2024 Q2	$135K	Buy	864 +475	+122%	+$71.5K	0.03%	404
2024 Q1	$52.6K	Buy	+389	New	+$51.5K	0.01%	788

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Point72 Asia (Singapore)'s AZN Position: Q3 2025 in Review

Point72 Asia (Singapore) opened a new position in AstraZeneca (AZN) in Q3 2025: 1,318 shares worth $202K. The stake represents 0.03% of the portfolio and ranks #300 among its holdings. This is a return to the name: Point72 Asia (Singapore) previously reported a position in AZN as recently as Q1 2025.

Point72 Asia (Singapore) first reported a position in AZN in Q1 2024 and has held it in 4 quarters since. 1,289 funds tracked by Wall St. Rank hold AZN as of Q3 2025.

Point72 Asia (Singapore) held 1,318 shares of AstraZeneca worth $202K as of Q3 2025.
AstraZeneca was a new Point72 Asia (Singapore) position in Q3 2025.
AstraZeneca made up 0.03% of Point72 Asia (Singapore)'s portfolio in Q3 2025, its #300 holding.
Point72 Asia (Singapore) first reported a position in AstraZeneca in Q1 2024 and has held it in 4 quarters since.
1,289 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.